Pioglitazone prevents morphine antinociceptive tolerance via ameliorating neuroinflammation in rat cerebral cortex

Background opioid induced neuroinflammation is shown to be implicated in opioid analgesic tolerance development. in the present study the effect of pioglitazone on morphine-induced tolerance and neuroinflammation in the cerebral cortex of the rat was investigated. materials and methods various groups of rats received morphine (10 mg/kg; ip) and vehicle (po),or morphine (10 mg/kg) and pioglitazone (20 or 40 mg/kg; po) once a day for 17 days. in order to determine the possible involvement of ppar-γ in the pioglitazone effect,one group of rats received ppar-γ antagonist,gw-9662 (2 mg/kg; sc),and pioglitazone (40 mg/kg) and morphine once daily for 17 days. nociception was assessed using a tail flick apparatus and the percentage of the maximal possible effect was calculated as well. on 18th day,2 h after the last morphine injection,the cerebral cortex of the animals were harvested and the tissue levels of tumour necrosis factor alpha,interleukin-1beta,interleukin-6,interleukin-10 and nuclear factor-kappa b activity were determined. results co-administration of pioglitazone (40 mg/kg) with morphine not only attenuated morphine-induced tolerance,but also prevented the up-regulation of pro-inflammatory cytokines (tumour necrosis factor alpha,interleukin-1beta,interleukin-6) and nuclear factor-kappa b activity in the rat cerebral cortex. moreover,gw-9662 (2 mg/kg) administration 30 min before pioglitazone,antagonized the above mentioned pioglitazone-induced effects. conclusion it is concluded that oral administration of pioglitazone attenuates morphine-induced tolerance. this effect of pioglitazone may be,at least in part,due to its anti-inflammatory property which suppressed the cortical pro-inflammatory cytokine and inhibited of nuclear factor-kappa b activity. © © 2014 institute of pharmacology,polish academy of sciences. published by elsevier urban and partner sp.z o.o. all rights reserved.